back to US directory
us clinical guidance

Acute cough and uncomplicated bronchitis stewardship

US assessment of acute cough, exclusion of pneumonia, antibiotic avoidance and return precautions for uncomplicated bronchitis.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Otherwise stable adults with an acute cough syndrome in outpatient care. The CDC uncomplicated-bronchitis pathway does not cover suspected pneumonia, pertussis, influenza or COVID-19 requiring treatment, COPD or asthma exacerbation, immunocompromise, heart failure or another serious cardiopulmonary cause. Children require age-specific assessment.
sources for this section:CDC adult outpatient 2024

The Bottom Line

  • Focus the initial examination on excluding pneumonia and another serious diagnosis; abnormal vital signs or focal consolidation findings change the pathway and may justify chest imaging.
  • Colored sputum does not demonstrate bacterial infection, and the duration or intensity of cough alone does not justify an antibiotic for uncomplicated acute bronchitis.
  • Do not routinely prescribe antibiotics for uncomplicated acute bronchitis regardless of cough duration; explain expected natural history and the individual and population harms of unnecessary treatment.
  • Symptomatic medicines have limited evidence and meaningful adverse effects, so choose selectively after reviewing age, pregnancy, comorbidity, interactions and the patient鈥檚 most troublesome symptom.
sources for this section:CDC adult outpatient 2024

Practical clinical workflow

1
Record symptom duration and trajectory, fever, dyspnea, pleuritic pain, hemoptysis, paroxysms, post-tussive vomiting, exposure, smoking, medication causes and chronic lung or cardiac disease.
2
Measure temperature, heart rate, respiratory rate and oxygenation when appropriate; examine for focal consolidation, wheeze, heart failure, upper-airway disease and venous-thromboembolism clues.
3
Test for influenza, SARS-CoV-2 or pertussis when timing, epidemiology and treatment or isolation decisions make the result actionable; avoid broad low-yield testing in a classic uncomplicated syndrome.
4
Give hydration and comfort advice, discuss a realistic cough course and set a follow-up threshold for worsening, new fever, breathlessness, dehydration or failure to improve as expected.
sources for this section:CDC adult outpatient 2024

Safety boundaries and escalation

  • Hypoxemia, respiratory distress, hypotension, confusion, focal chest findings, persistent high fever, significant hemoptysis or a high-risk host requires urgent evaluation beyond uncomplicated bronchitis guidance.
  • A normal examination does not automatically exclude pulmonary embolism, acute coronary syndrome or heart failure when the history supports them; use the appropriate emergency diagnostic pathway.
  • Suspected pertussis in an infant contact, pregnancy or another high-risk exposure needs prompt testing, treatment and public-health action rather than routine bronchitis reassurance.
  • Avoid opioid antitussives and sedating combinations without a specific risk-benefit assessment; product age restrictions, respiratory depression, falls and drug interactions are clinically important.
sources for this section:CDC adult outpatient 2024

Localization

CDC adult outpatient stewardship is the governing US source for this uncomplicated syndrome. State respiratory-disease reporting, local testing availability and antiviral pathways matter.
sources for this section:CDC adult outpatient 2024

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Centers for Disease Control and PreventionOutpatient Clinical Care for Adults: Antibiotic Prescribing and Useupdated 2024-04-16 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.